IDEXX Laboratories Inc
NASDAQ:IDXX
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
406.92
576.87
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
IDEXX Laboratories Inc
IDEXX Laboratories Inc
Revenue
IDEXX Laboratories Inc
Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
Revenue
$3.8B
|
CAGR 3-Years
7%
|
CAGR 5-Years
10%
|
CAGR 10-Years
10%
|
|
|
Becton Dickinson and Co
NYSE:BDX
|
Revenue
$20.2B
|
CAGR 3-Years
2%
|
CAGR 5-Years
3%
|
CAGR 10-Years
9%
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Revenue
$15.9B
|
CAGR 3-Years
12%
|
CAGR 5-Years
9%
|
CAGR 10-Years
8%
|
|
|
Stryker Corp
NYSE:SYK
|
Revenue
$22B
|
CAGR 3-Years
10%
|
CAGR 5-Years
9%
|
CAGR 10-Years
9%
|
|
|
Abbott Laboratories
NYSE:ABT
|
Revenue
$41.2B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
6%
|
CAGR 10-Years
8%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Revenue
$7.9B
|
CAGR 3-Years
13%
|
CAGR 5-Years
13%
|
CAGR 10-Years
14%
|
|
IDEXX Laboratories Inc
Revenue Breakdown
Breakdown by Geography
IDEXX Laboratories Inc
|
Total Revenue:
3.7B
USD
|
|
Americas:
2.6B
USD
|
|
Europe, The Middle East And Africa:
716.2m
USD
|
|
Asia Pacific Region:
319.3m
USD
|
|
Canada:
150.1m
USD
|
|
Switzerland:
34.8m
USD
|
Breakdown by Segments
IDEXX Laboratories Inc
|
Total Revenue:
3.7B
USD
|
|
Cag Segment Revenue:
3.4B
USD
|
|
Cag Diagnostics Recurring Revenue::
2.9B
USD
|
|
Product Revenue:
2.1B
USD
|
|
Service Revenue:
1.6B
USD
|
|
Reference Laboratory Diagnostic And Consultin...:
1.3B
USD
|
|
Rapid Assay Products:
344.5m
USD
|
|
Veterinary Software, Services And Diagnostic ...:
279.3m
USD
|
|
Water Segment Revenue:
168.1m
USD
|
|
Cag Diagnostics Capital - Instruments:
137.6m
USD
|
|
Lpd Segment Revenue:
121.7m
USD
|
|
Other Segment Revenue:
18.8m
USD
|
IDEXX Laboratories Inc
Glance View
IDEXX Laboratories Inc. stands as a pillar of innovation in the realm of veterinary diagnostics, transforming the landscape of animal healthcare. Founded in 1983, the company has strategically positioned itself at the intersection of science and care, delivering a broad range of products and services that cater primarily to veterinarians. By offering state-of-the-art diagnostic tests and in-house laboratory equipment, IDEXX empowers veterinarians to make precise and timely decisions. These tools not only enhance animal health but also streamline veterinary practices, allowing them to offer clients rapid, reliable results. By investing heavily in research and development, IDEXX continuously enhances its product portfolio, maintaining a competitive edge in a market that demands constant innovation. In addition to its core veterinary diagnostic services, IDEXX extends its expertise into water testing and livestock and poultry diagnostics, though these segments are smaller. The company crafts its revenue model on providing recurring, subscription-based services for its diagnostic machines, which require regular updating with new test kits and consumables. This model ensures a durable revenue stream, fostering long-term relationships with veterinary clinics worldwide. As digital transformation sweeps through every industry, IDEXX has also embraced the digital age, crafting sophisticated software that aids veterinarians in managing their practices more efficiently, thus augmenting its revenue through IT solutions. This diversified yet synergistic approach has allowed IDEXX to remain resilient and grow steadily, delivering consistent value to both its clients and shareholders.
See Also
What is IDEXX Laboratories Inc's Revenue?
Revenue
3.8B
USD
Based on the financial report for Sep 30, 2024, IDEXX Laboratories Inc's Revenue amounts to 3.8B USD.
What is IDEXX Laboratories Inc's Revenue growth rate?
Revenue CAGR 10Y
10%
Over the last year, the Revenue growth was 7%. The average annual Revenue growth rates for IDEXX Laboratories Inc have been 7% over the past three years , 10% over the past five years , and 10% over the past ten years .
You don't have any saved screeners yet
